3T Biosciences

OverviewSuggest Edit

3T Biosciences is an immunotherapy company. It develops therapies against cancer by combining experimental biology and artificial intelligence. The Company uses machine learning to predict what chemicals affect cancer cells and modifies T cells. 

TypePrivate
Founded2017
HQSouth San Francisco, CA, US
Website3tbiosciences.com

Latest Updates

Employees (est.) (Sept 2021)21
Cybersecurity ratingAMore

Key People/Management at 3T Biosciences

Marvin Gee

Marvin Gee

Co-Founder, Head of Target Discovery
John Connolly

John Connolly

Interim CEO
Leah Sibener

Leah Sibener

Co-Founder, Head of Therapeutic Discovery
Hanspeter Gerber

Hanspeter Gerber

Chief Scientific Officer
Glenn Dourado

Glenn Dourado

Chief Business Officer
Javier Chaparro-Riggers

Javier Chaparro-Riggers

Executive Director, Biotherapeutic Design & Discovery, Pfizer
Show more

3T Biosciences Office Locations

3T Biosciences has an office in South San Francisco
South San Francisco, CA, US (HQ)
Building 84, 681 Gateway Blvd
Show all (1)

3T Biosciences Financials and Metrics

Summary Metrics

Founding Date

2017

3T Biosciences total Funding

$12 m

3T Biosciences latest funding size

$12 m

Time since last funding

4 years ago

3T Biosciences investors

3T Biosciences's latest funding round in October 2017 was reported to be $12 m. In total, 3T Biosciences has raised $12 m
Show all financial metrics

3T Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

3T Biosciences Online and Social Media Presence

Embed Graph

3T Biosciences Blogs

3T Biosciences to Present at BIO CEO & Investor Digital Conference

John Connolly, Ph.D., interim CEO, and Hanspeter Gerber, Ph.D., Chief Scientific Officer, will participate in the BIO CEO & Investor Digital Conference, February 16-18, 2021. Dr. Connolly, will present an overview of the company and 3T-TRACE, a technology that applies…

3T Biosciences to Present at Biotech Showcase Digital 2021

John Connolly, Ph.D., interim CEO of 3T Biosciences, will present an overview of the company and 3T-TRACE, a technology that applies a yeast display platform and active machine learning to identify novel targets and T-cell receptors (TCRs), at the Biotech…

3T Biosciences Appoints Industry Veteran John Connolly as Interim CEO

Media contact: Lissa Quirino, pr@3tbiosciences.com SOUTH SAN FRANCISCO, December 14, 2020 — 3T Biosciences, an immunotherapy company, today announced that John Connolly, Ph.D. has been appointed as interim CEO. Together with the current leadership team, Dr. Connolly will lead the…

3T Biosciences Frequently Asked Questions

  • When was 3T Biosciences founded?

    3T Biosciences was founded in 2017.

  • Who are 3T Biosciences key executives?

    3T Biosciences's key executives are Marvin Gee, John Connolly and Leah Sibener.

  • How many employees does 3T Biosciences have?

    3T Biosciences has 21 employees.

  • Who are 3T Biosciences competitors?

    Competitors of 3T Biosciences include Virogin Biotech, Silverback Therapeutics and Meabco.

  • Where is 3T Biosciences headquarters?

    3T Biosciences headquarters is located at Building 84, 681 Gateway Blvd, South San Francisco.

  • Where are 3T Biosciences offices?

    3T Biosciences has an office in South San Francisco.

  • How many offices does 3T Biosciences have?

    3T Biosciences has 1 office.